| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0009 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |